Covid-19 roundup: FDA gives OK to use extra doses in Pfizer/BioNTech vaccine vials; Sinopharm's Peru trial to resume
While Pfizer and the US government are still negotiating for more doses of its BioNTech-partnered mRNA vaccine, the FDA has cleared the way for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
